KVP Capital Advisors as of June 30, 2026
Portfolio Holdings for KVP Capital Advisors
KVP Capital Advisors holds 35 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Praxis Precision Medicines I Com New (PRAX) | 10.5 | $14M | 43k | 334.79 | |
| Aadi Bioscience (WHWK) | 7.3 | $9.9M | 2.2M | 4.58 | |
| Erasca (ERAS) | 6.1 | $8.3M | 455k | 18.32 | |
| Trevi Therapeutics (TRVI) | 5.7 | $7.7M | 414k | 18.65 | |
| Sutro Biopharma Com Shs (STRO) | 5.5 | $7.5M | 227k | 33.20 | |
| Tango Therapeutics (TNGX) | 5.3 | $7.2M | 230k | 31.26 | |
| Mbx Biosciences (MBX) | 4.9 | $6.7M | 122k | 55.20 | |
| Protagonist Therapeutics (PTGX) | 4.8 | $6.5M | 53k | 122.58 | |
| Edgewise Therapeutics (EWTX) | 4.0 | $5.4M | 133k | 40.63 | |
| Tandem Diabetes Care Com New (TNDM) | 3.3 | $4.5M | 301k | 15.09 | |
| Disc Medicine (IRON) | 3.1 | $4.3M | 58k | 73.14 | |
| Savara (SVRA) | 2.7 | $3.7M | 605k | 6.16 | |
| Arrivent Biopharma (AVBP) | 2.6 | $3.5M | 102k | 34.74 | |
| Insmed Com Par $.01 (INSM) | 2.2 | $3.0M | 29k | 106.62 | |
| Achieve Life Sciences (ACHV) | 2.2 | $3.0M | 462k | 6.53 | |
| Ideaya Biosciences (IDYA) | 2.2 | $3.0M | 80k | 37.27 | |
| Ocular Therapeutix (OCUL) | 2.2 | $2.9M | 300k | 9.82 | |
| Axsome Therapeutics (AXSM) | 2.2 | $2.9M | 12k | 244.77 | |
| Design Therapeutics (DSGN) | 2.0 | $2.7M | 185k | 14.47 | |
| United Therapeutics Corporation (UTHR) | 1.9 | $2.6M | 4.8k | 541.83 | |
| Scholar Rock Hldg Corp (SRRK) | 1.8 | $2.5M | 45k | 55.00 | |
| Immix Biopharma (IMMX) | 1.7 | $2.4M | 230k | 10.31 | |
| Miragen Therapeutics (VRDN) | 1.7 | $2.3M | 125k | 18.37 | |
| Mineralys Therapeutics (MLYS) | 1.7 | $2.3M | 84k | 26.98 | |
| Bright Minds Biosciences Com New (DRUG) | 1.6 | $2.2M | 32k | 70.20 | |
| Travere Therapeutics (TVTX) | 1.6 | $2.2M | 39k | 56.81 | |
| Zura Bio Class A Ord Shs (ZURA) | 1.6 | $2.2M | 373k | 5.90 | |
| Artiva Biotherapeutics (ARTV) | 1.4 | $1.9M | 200k | 9.70 | |
| Nektar Therapeutics Com New (NKTR) | 1.4 | $1.9M | 27k | 69.81 | |
| Compass Therapeutics (CMPX) | 1.2 | $1.7M | 771k | 2.19 | |
| Cabaletta Bio (CABA) | 1.2 | $1.6M | 505k | 3.11 | |
| Vera Therapeutics Cl A (VERA) | 1.0 | $1.4M | 33k | 42.91 | |
| Evolus (EOLS) | 0.8 | $1.0M | 150k | 6.94 | |
| Celcuity (CELC) | 0.3 | $419k | 4.0k | 104.62 | |
| Vyne Therapeutics (VYNE) | 0.2 | $326k | 501k | 0.65 |